Apellis Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference

Company Announcement - Apellis Pharmaceuticals will present at the TD Cowen 45 Annual Health Care Conference on March 3, 2025, at 10:30 a.m. ET [1] - A live webcast of the conference will be available on the company's website, with a replay accessible for approximately 90 days post-event [1] Company Overview - Apellis Pharmaceuticals is a global biopharmaceutical company focused on developing therapies for challenging diseases [2] - The company has introduced the first new class of complement medicine in 15 years, with two approved medicines targeting C3 [2] - Apellis has developed the first-ever therapy for geographic atrophy, a major cause of blindness globally, and aims to explore the potential of targeting C3 in various serious diseases [2]